if this csiro trial on lung epithelial cells passes (stage 2 say) then the possibility of using recce in a nebuliser ie like an asthma inhalant is on the cards for use under the TGA special circumstances application possibly wow thats fast track and this is a side game ! i see next few weeks very positive maybe a week or two more than that but i dont want to be chasing a tigers tail i bought more today despite the rise catching us by suprise last few days i dont want to sit fuming “ if only i bought more at 68! “ cheers hope im right but i feel very positive im on a winner here still early phase 2 trial deals with the real big pharma start low at $350 mill and can be up to $1.5 bill im working on the lower price so i can get very suprised and excited on that day ! Ha ha current ca
RCE Price at posting:
$1.05 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)